Related Experiment Video
Updated: Mar 28, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Endothelial Dysfunction by Flow-Mediated Vasodilatation in Chronic Kidney Disease
Chronic kidney disease (CKD) patients exhibit significant endothelial dysfunction, particularly in later disease stages. This dysfunction, assessed via flow-mediated brachial artery vasodilatation, is more pronounced compared to healthy individuals.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Vascular Biology
Background:
- Chronic kidney disease (CKD) prevalence is rising globally.
- Cardiovascular disease is the leading cause of mortality in CKD patients.
- Endothelial dysfunction is a key factor in cardiovascular complications.
Purpose of the Study:
- To investigate endothelial dysfunction in CKD patients.
- To compare endothelial function between CKD patients and healthy controls.
- To assess the relationship between CKD stage and endothelial dysfunction.
Main Methods:
- Study included 35 CKD patients and 32 age/sex-matched controls.
- Flow-mediated vasodilatation (FMD) of the brachial artery was assessed.
- Anthropometric, hematological, and biochemical parameters were measured.
Main Results:
- CKD patients demonstrated significant endothelial dysfunction compared to controls, as measured by FMD.
- Endothelial dysfunction was more severe in advanced stages of CKD.
- Biochemical and anthropometric data supported the findings of impaired vascular function.
Conclusions:
- CKD is associated with significant endothelial dysfunction.
- The severity of endothelial dysfunction increases with CKD progression.
- Targeting endothelial dysfunction may be crucial for managing cardiovascular risk in CKD.
More Related Videos
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

